Xilio Therapeutics XLO
NASDAQ XLO
$8.47 -0.06 (-0.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Xilio Therapeutics (XLO) Shares Outstanding (2020 - 2026)

Updated

Xilio Therapeutics (XLO) posted Weighted Average Shares Outstanding of 19.4 million for Q2 2026, up 181.7% from 6.89 million a year earlier and up 18.7% from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Shares Outstanding (2020 - 2026) Analysis & Trends

For FY2025, Xilio Therapeutics' Weighted Average Shares Outstanding came in at 8.36 million, up 118.7% from FY2024.

  • Annual Weighted Average Shares Outstanding has increased for five consecutive years, with a five-year compound annual growth rate of 195.0% (FY2020 to FY2025).
  • In prior years, Xilio Therapeutics' Weighted Average Shares Outstanding was 3.82 million in FY2024 (+94.6%), 1.96 million in FY2023 (+0.4%), 1.96 million in FY2022 (+388.6%) and 400,451 in FY2021 (+970.4%).
  • The Q2 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding in data going back to Q3 2020.
  • On a year-over-year basis, Weighted Average Shares Outstanding has increased in each of the last 15 quarters, with growth averaging 136.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding ranged from 0.2% (Q1 2023) to 970.4% (Q4 2021).
  • According to Business Quant data, Weighted Average Shares Outstanding for the three prior quarters was 16.35 million (Q1 2026), 8.36 million (Q4 2025) and 10.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.94 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.55 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.24 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.70 Bn
10 Xilio Therapeutics 167.94 Mn -378.15 Mn - 19.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 19.69 Mn
Jun 30, 2026 19.40 Mn
Mar 31, 2026 16.35 Mn
Dec 31, 2025 8.36 Mn
Sep 30, 2025 10.29 Mn
Jun 30, 2025 6.89 Mn
Mar 31, 2025 5.34 Mn
Dec 31, 2024 3.82 Mn
Sep 30, 2024 4.53 Mn
Jun 30, 2024 4.13 Mn
Mar 31, 2024 1.99 Mn
Dec 31, 2023 1.96 Mn
Sep 30, 2023 1.97 Mn
Jun 30, 2023 1.96 Mn
Mar 31, 2023 1.96 Mn
Dec 31, 2022 1.96 Mn
Sep 30, 2022 1.96 Mn
Jun 30, 2022 1.96 Mn
Mar 31, 2022 1.95 Mn
Dec 31, 2021 400,451.00
API Access

Xilio Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=XLO&period=max&api_key=YOUR_API_KEY